Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent
about
Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriAlpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitroIntracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivoEfficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in miceAnti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivativesSusceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitorsDifferential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurineAntiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenineSRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virusAntiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newbIsolation, characterization, molecular cloning and molecular modelling of two lectins of different specificities from bluebell (Scilla campanulata) bulbsSynthesis and biological activities of new carbaacyclonucleosides and 1'-oxaacyclonucleosides related to clitocine.Inhibition of HIV-1 integrase by modified oligonucleotides derived from U5' LTR.Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians.Oral, subcutaneous, and intramuscular bioavailabilities of the antiviral nucleotide analog 9-(2-phosphonylmethoxyethyl) adenine in cynomolgus monkeysSingle-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type 1. The Pediatrics AIDS Clinical Trials GroupAntiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucksInhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine on visna virus infection in lambs: a model for in vivo testing of candidate anti-human immunodeficiency virus drugs.Acyclic nucleoside phosphonates: a key class of antiviral drugs.Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cellsClinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients.Antiviral therapy for human immunodeficiency virus infectionsIn search of a selective antiviral chemotherapy.Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.Polymerase-catalyzed synthesis of DNA from phosphoramidate conjugates of deoxynucleotides and amino acids.Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenineBiochemical pharmacology of acyclic nucleotide analogues.Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.Polymerases of paramyxoviruses and pneumoviruses.Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonatesTransport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated(R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection.Short synthesis and antiviral activity of acyclic phosphonic acid nucleoside analogues.Synthesis of acyclic nucleoside phosphonates.2'C-alkoxy and 2'-C-aryloxy derivatives of N-(2-phosphonomethoxyethyl)-purines and -pyrimidines: synthesis and biological activity.Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation.Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12.
P2860
Q24672068-5F9042C6-DC5A-4146-82CB-9828F4494A5CQ28316183-9BCC8D5E-209D-4304-A503-4536EB9D7DD2Q28321244-11CA8251-814D-4095-98B5-44930E72EF67Q28323687-CE685C22-E349-4795-AD92-1047E7B7B361Q28323877-29BB53D4-B691-4331-A172-C3D0B44DF35BQ28328542-C46D2E9D-8CA4-41E1-A8BB-B6FD0EF95BE9Q28328852-5B43EB39-34E0-4C0C-B3AA-9083B9B577CAQ28343399-8A8094ED-FF7A-4296-89F8-B352320749BAQ28378681-C1DD0261-FE29-4A17-84D5-91D88FD3A4E2Q28379083-D1C0AC0C-77B6-4AB4-8966-51B8F1AE2BDAQ28379459-55AD1E96-8BBF-4752-9A85-DF9C6F4369EDQ28379501-098E1D26-4115-4CC7-9A7B-7DF2CDAF73E3Q30680954-E5556600-F964-4EE2-9604-7A7BD18C332CQ31393121-41469D65-B337-4880-B3F3-23B71C707106Q31944552-C76EB92A-9026-4C3B-9E4E-26A58685CBCEQ31975873-FB2F8B1A-2F93-44F8-88B8-FB638F70ECD1Q33749762-E57EFC4E-7E7A-4A16-9D90-F1014E587125Q33979222-85E73E1F-5C4E-461B-B19C-C766B778EE15Q33983079-85D04B77-D045-44C3-A02F-6BC6B874E625Q34429807-07D1ACB4-2336-46C8-883F-AAD166827F20Q34464655-4EB81307-0B29-4669-A495-619E79080C10Q35119748-B1433936-A27E-46F1-97E6-61A7D18EAA3CQ35120136-03C23AB2-6AE4-43DA-A07F-EC7C84F12090Q35366050-CDCF57DF-B679-4126-A7D8-97B026F6E9BBQ35375912-4E9CC360-8F11-4831-BBFD-32EF74AA708CQ35903936-DD9C5659-A6A3-4EE3-8255-4B14775337FEQ35990894-1F8501D4-F324-4C0E-8383-BAEB9E4CBC39Q37740890-614D2203-644F-4825-BFFB-185E9B7BA5E0Q37783046-0733944C-8485-4B47-B457-4163755915F7Q38009758-CA228BB3-61D6-4725-B9BB-BBC2FC76D7C9Q38097391-A7572806-E321-452C-A001-2C77B9E80944Q39011481-F9E62897-FDD3-4E91-8852-830ADEBAFFDEQ39652313-5C9273E5-525D-4DFA-9965-B2265599EC0CQ39778904-36A2DC82-0BE6-4236-87E6-EDE175459FC0Q39779394-7BA6E900-0767-44A0-A3BD-11A352424669Q39883520-88FF5E23-786D-4DA3-977E-D3703B5644EFQ40100237-DCE9BC0A-65CD-4872-BB70-3CB06C6C8760Q40780891-E3C4B199-C9D8-4437-B40E-36BC095A95F0Q40983879-71081F7D-DAFF-42B2-A478-DE5B2730B14AQ40983909-7183873C-EDBA-4098-9E78-AFB9F2DCDE8D
P2860
Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@ast
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@en
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@nl
type
label
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@ast
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@en
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@nl
prefLabel
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@ast
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@en
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@nl
P2093
P2860
P50
P356
P1476
Marked in vivo antiretrovirus ...... n immunodeficiency virus agent
@en
P2093
P2860
P356
10.1073/PNAS.86.1.332
P407
P577
1989-01-01T00:00:00Z